Title:
レチノイン酸受容体における活性を伴う化合物
Document Type and Number:
Japanese Patent JP2009501721
Kind Code:
A
Abstract:
Disclosed herein are novel compounds with activity at RARbeta 2 receptors. Further disclosed are the use of such compounds for treatment of or to alleviate symptoms of cancer, neurological disorders such as memory deficits and schizophrenia, neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, inflammatory disorders such as psoriasis and rheumatoid arthritis, eye disorders and depression.
Inventors:
Olson, Roger
Piu, Fabrice
Gundersen, Bilgit
Piu, Fabrice
Gundersen, Bilgit
Application Number:
JP2008521652A
Publication Date:
January 22, 2009
Filing Date:
July 12, 2006
Export Citation:
Assignee:
Acadia Pharmaceuticals, Inc.
International Classes:
C07C63/331; A61K31/192; A61K31/275; A61K31/341; A61K31/4164; A61K31/4196; A61K31/426; A61K31/44; A61P3/10; A61P9/00; A61P17/06; A61P25/00; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P27/02; A61P29/00; A61P35/00; C07C63/70; C07C65/24; C07C255/16; C07D213/75; C07D233/60; C07D249/14; C07D277/20; C07D277/34; C07D307/40
Attorney, Agent or Firm:
Yoshiyuki Inaba
Shinji Oga
Toshifumi Onuki
Shinji Oga
Toshifumi Onuki